Predict your next investment

Cytometix company logo
HEALTHCARE | Pharmaceuticals / Drugs
cytometix.com

See what CB Insights has to offer

Stage

Unattributed VC | Alive

Total Raised

$1.91M

Last Raised

$1.91M | 11 yrs ago

About Cytometix

Cytometic is an early stage pharmaceuticals company focused on pre clinical development of novel therapeutics.

Cytometix Headquarter Location

756 North Milwaukee Street Suite 250

Milwaukee, Wisconsin, 53202,

United States

414-727-1726

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Cytometix

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Cytometix is included in 1 Expert Collection, including Biopharmaceuticals.

B

Biopharmaceuticals

5,882 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

Cytometix Patents

Cytometix has filed 3 patents.

The 3 most popular patent topics include:

  • Alkenoic acids
  • Analgesics
  • Eicosanoids
patents chart

Application Date

Grant Date

Title

Related Topics

Status

5/3/2016

4/6/2021

Fatty acids, G protein coupled receptors, Eicosanoids, Analgesics, Alkenoic acids

Grant

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Application Date

5/3/2016

00/00/0000

00/00/0000

Grant Date

4/6/2021

00/00/0000

00/00/0000

Title

Subscribe to see more

Subscribe to see more

Related Topics

Fatty acids, G protein coupled receptors, Eicosanoids, Analgesics, Alkenoic acids

Subscribe to see more

Subscribe to see more

Status

Grant

Subscribe to see more

Subscribe to see more

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.